Choline
Diagnostic imaging
Positron emission tomography
Prostatic neoplasms
Journal
Prostate international
ISSN: 2287-8882
Titre abrégé: Prostate Int
Pays: Korea (South)
ID NLM: 101605566
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
02
10
2018
revised:
26
11
2018
accepted:
08
01
2019
entrez:
6
9
2019
pubmed:
6
9
2019
medline:
6
9
2019
Statut:
ppublish
Résumé
The use of molecular imaging in staging of prostate cancer (PC) is debated. In patients with newly diagnosed PC we investigated the diagnostic value of Between January 2013 and April 2016, 143 patients, aged 49-83, mean 69, years with newly diagnosed PC and disease characteristics necessitating WBS underwent both WBS and Bone metastases were detected in 8/143 patients and sensitivity and specificity of WBS were 37.5% and 85.2% versus 100.0% and 96.3% with Findings in this study suggested that
Sections du résumé
BACKGROUND
BACKGROUND
The use of molecular imaging in staging of prostate cancer (PC) is debated. In patients with newly diagnosed PC we investigated the diagnostic value of
MATERIALS AND METHODS
METHODS
Between January 2013 and April 2016, 143 patients, aged 49-83, mean 69, years with newly diagnosed PC and disease characteristics necessitating WBS underwent both WBS and
RESULTS
RESULTS
Bone metastases were detected in 8/143 patients and sensitivity and specificity of WBS were 37.5% and 85.2% versus 100.0% and 96.3% with
CONCLUSIONS
CONCLUSIONS
Findings in this study suggested that
Identifiants
pubmed: 31485437
doi: 10.1016/j.prnil.2019.01.002
pii: S2287-8882(18)30113-2
pmc: PMC6713799
doi:
Types de publication
Journal Article
Langues
eng
Pagination
119-123Références
BJU Int. 1999 Dec;84(9):1028-31
pubmed: 10571628
J Nucl Med. 2003 Mar;44(3):331-5
pubmed: 12620996
J Cell Biochem. 2004 Feb 15;91(3):528-39
pubmed: 14755683
J Nucl Med. 2006 Feb;47(2):287-97
pubmed: 16455635
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1683-92
pubmed: 17661031
Clin Radiol. 2008 Apr;63(4):387-95
pubmed: 18325358
Mol Imaging Biol. 2010 Jan-Feb;12(1):98-107
pubmed: 19588206
Radiology. 2010 Mar;254(3):925-33
pubmed: 20177103
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):14-22
pubmed: 20862471
Eur Urol. 2011 Jan;59(1):61-71
pubmed: 21056534
Nucl Med Commun. 2011 Mar;32(3):168-76
pubmed: 21076343
Med Phys. 2011 Oct;38(10):5394-411
pubmed: 21992359
BJU Int. 2012 Dec;110(11):1666-71
pubmed: 22520686
Eur Urol. 2013 Jun;63(6):1040-8
pubmed: 23036576
J Urol. 2013 Apr;189(4):1308-13
pubmed: 23123372
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
pubmed: 24072344
Eur J Cancer. 2015 Jun;51(9):1164-87
pubmed: 24120180
BJU Int. 2014 Dec;114(6):818-23
pubmed: 24314065
Prostate. 2014 Aug;74(11):1153-9
pubmed: 24913988
Cancer Imaging. 2015 Mar 03;15:2
pubmed: 25889163
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1723-38
pubmed: 27262701
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S
pubmed: 28864615
J Nucl Med. 2018 Jul;59(7):1165
pubmed: 28916624
World J Urol. 2018 Apr;36(4):519-527
pubmed: 29344682
BJU Int. 2018 Nov;122(5):783-793
pubmed: 29726071
World J Urol. 2019 Jul;37(7):1255-1261
pubmed: 30374609
Annu Rev Nutr. 1981;1:95-121
pubmed: 6764726
Radiology. 1996 Jun;199(3):751-6
pubmed: 8638000
J Nucl Med. 1997 Jun;38(6):842-7
pubmed: 9189127
Urology. 1999 Feb;53(2):367-71
pubmed: 9933056